ZA200209309B - Bidentate ligands useful in catalyst system. - Google Patents

Bidentate ligands useful in catalyst system. Download PDF

Info

Publication number
ZA200209309B
ZA200209309B ZA200209309A ZA200209309A ZA200209309B ZA 200209309 B ZA200209309 B ZA 200209309B ZA 200209309 A ZA200209309 A ZA 200209309A ZA 200209309 A ZA200209309 A ZA 200209309A ZA 200209309 B ZA200209309 B ZA 200209309B
Authority
ZA
South Africa
Prior art keywords
atoms
bidentate ligand
substituted
group
catalyst system
Prior art date
Application number
ZA200209309A
Inventor
Eit Drent
Michael Rolf Eberhard
Paul Gerard Pringle
Original Assignee
Shell Int Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8172999&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200209309(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shell Int Research filed Critical Shell Int Research
Publication of ZA200209309B publication Critical patent/ZA200209309B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/36—Preparation of carboxylic acid esters by reaction with carbon monoxide or formates
    • C07C67/38—Preparation of carboxylic acid esters by reaction with carbon monoxide or formates by addition to an unsaturated carbon-to-carbon bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5027—Polyphosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • C07F9/65683—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms the ring phosphorus atom being part of a phosphine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Bidentate ligand of formula II,wherein M<1 >and M<2 >are independently P, As or Sb; R<1>, R<2>, R<3 >and R<4 >independently represent tertiary alkyl groups, or R<1 >and R<2 >together and/or R<3 >and R<4 >together represent an optionally substituted bivalent cycloaliphatic group whereby the two free valencies are linked to M<1 >or M<2>, and R represents a bivalent aliphatic bridging group containing from 2 to 6 atoms in the bridge, which is substituted with two or more substituents. A catalyst system comprising:a) a source of group VIII metal cations;b) a source of such a bidentate ligand; andc) a source of anions, and use of such a catalyst system in a process for the carbonylation of optionally substituted ethylenically or acetylenically unsaturated compounds by reaction with carbon monoxide and a coreactant is provided.

Description

' . . BIDENTATE LIGANDS USEFUL IN CATALYST SYTEMS a
This invention relates to a bidentate ligand of formula TI, 0lo2vi-0-v29304 (1) wherein V1 and V2 are independently P, As or Sb; ol, 02, 03 and 04 represent hydrocarbyl groups and R represents a bivalent bridging group. The invention further relates to a catalyst system containing such a bidentate ligand, a source of group VIII metal cations and a source of anions. Moreover, the invention relates to a process for the carbonylation of optionally substituted ethylenically or acetylenically unsaturated compounds by reaction with carbon monoxide and a coreactant in the presence of such a catalyst system.
One commercially important carbonylation reaction using hydrogen as coreactant, is the hydroformylation of alkenes or alkynes, which are reacted with carbon monoxide and hydrogen in the presence of transition metal catalysts to form aldehydes and/or alcohols having one carbon atom more than the precursor alkene or alkyne.
Depending on catalyst, reaction conditions and substrates, the hydroformylation may proceed with varying selectivities to the several possible isomeric aldehydes or alcohols in varying yields, as side reactions occur to 4 a smaller or larger extent. Generally only one isomeric ' 25 product is preferred. For many applications the presence of branched aldehydes or alcohols is undesirable.
Moreover, in view of biological degradability, it is considered advantageous to obtain products having a high content of the linear isomer. The selectivity towards one ) 5 of several possible isomeric products is called regioselectivity. For hydroformylation a regioselectivity towards reaction at the primary carbon atom, resulting in a linear product, is desirable.
Another commercially important carbonylation reaction using an alkanol or water as coreactant, is the carbonylaticn of alkenes or alkynes, which are reacted with carbon monoxide and alkanol in the presence of Group
VIII metal catalysts to form esters, diesters or carboxylic acids. An example of such a carbonylation is the reaction of ethene with carbon monoxide and butanol to prepare butylpropionates.
CA-A-2086285 relates to the preparation of diphosphines, wherein an alkane, alkene or arene is vicinally disubstituted with two organophosphino groups.
The bidentate diphosphines are said to be useful in the preparation of catalysts for the preparation of polyketones. In example 13 the preparation of 2,3 bis (di- isobutylphosphino) pentane) is described.
WO 9505354 describes the hydroformylation of ethylenically unsaturated compounds by reaction with carbon monoxide and hydrogen in the presence of a catalyst system comprising a Group VIII metal cation, viz. cationic palladium, and a bidentate ligand, viz. a . diphosphine. In the examples several bidentate v 30 diphosphines are used. As is illustrated by examples 46 and 47 the hydroformylation of l-octene with a catalyst system containing a bidentate diphosphine results in acceptable selectivities towards the linear product. The results show that the use of a bidentate diphosphine having an unsubstituted bivalent organic bridging group, connecting both phosphorus atoms, i.e. ] 1,2-bis—-(1,4-cyclooctylenephosphino) ethane, results in higher selectivities towards the linear product than the use of a bidentate diphosphine having an monosubstituted bivalent organic bridging group, connecting both phosphorus atoms, i.e. 1,2-bis(1,4-cyclooctylene- phosphino) propane. Hence, this patent document teaches that non-substituted bridging groups are advantageous compared to substituted bridging groups.
Although good results with regard to this regio- selectivity towards the linear product are obtained in
WO 9505354, there is still room for improvement. This need especially exists with regard to smaller ethylenically unsaturated compounds, where side-reactions more readily occur.
Examples 28 to 36 of EP-A-0495547 describe a carbonylation of ethene with carbon monoxide and n-butanol in the presence of bidentate diphosphines having an unsubstituted bivalent organic bridging group, connecting both phosphorus atoms, i.e. 1,3-bis(di- isopropylphosphino) propane; 1,3-bis(di-ethylphosphino) propane; 1,3-bis(di-s-butylphosphino) propane, 1,3-bis- (di-phenylphosphino) propane. Selectivities of 98% and rates of conversion in the range from 100 to 1000 mol butylpropionate/mol Pd/hr are obtained.
Although good results with regard to selectivity and ] activity are obtained in EP-A-0495547, there is still w 30 room for improvement. : It has now surprisingly been found that when carbonylation is carried out in the presence of a catalyst system that is characterized by a specific choice of bidentate ligand containing a polysubstituted bridging group, unexpected advantages with regard to the regioselectivity and/or activity are obtained. ) Accordingly this invention provides a bidentate ligand of formula II, ~ RIRZM1-R-M2R3R4 (IT) wherein M1 and M2 are independently P, As or Sb; RI, RZ,
R3 and R4 independently represent tertiary alkyl groups, or Rl and RZ together and/or R3 and R4 together represent an optionally substituted bivalent cycloaliphatic group whereby the two free valencies are linked to M! or MZ, and R represents a bivalent aliphatic bridging group containing from 2 to 6 atoms in the bridge, which is substituted with two or more substituents.
Surprisingly it was found that a catalyst system comprising such a bidentate ligand having a polysubstituted bivalent aliphatic bridging group results in a high regioselectivity towards the linear product and/or a higher activity.
In the bidentate ligand of formula II, M1 and M2 are preferably the same and more preferably they both represent phosphorus atoms.
By “a bridge” is understood the shortest connection between the atoms M! and M?. This bridge can be saturated or non-saturated or can form part of an optionally substituted saturated or non-saturated aliphatic ring structure, comprising one or more rings. The bridge can . further contain heteroatoms such as nitrogen, sulphur, - silicon or oxygen atoms. Preferably at least the atoms in the bridge connected to Ml and M2 are carbon atoms, more preferably all atoms in the bridge are carbon atoms.
The bridge connecting M1 and M2 forms part of a bridging group R, which can be saturated or unsaturated and which can be an optionally substituted saturated or non-saturated aliphatic ring structure, such as for ] 5 example cyclohexane, cyclohexene, cyclopentane or cyclopentene. The bridging group can further contain heteroatoms such as nitrogen, sulphur, silicon or oxygen atoms. Unsaturated bonds and/or heteroatoms can be present in each part of the bridging group R, both within 10 and outside the bridge. If the bridging group R is a cycleoaliphatic ring structure, the ring may be interrupted by one or more heteroatoms such as nitrogen, sulphur, silicon or oxygen atoms. The aliphatic ring structure can further be substituted with any kind of 15 substituent, including heteroatoms, alkylgroups, cycloalkyl groups and aryl groups, both within as well as outside the bridge.
The bivalent aliphatic bridging group R, connecting the atoms Ml and M2 contains from 2 to 6 atoms in the 20 bridge, more preferably 2 to 4 atoms, and most preferably 2 to 3 atoms. Preferably the atoms in the bridge are carbon atoms. Bivalent aliphatic bridging groups R, containing 2 carbon atoms in the bridge are especially preferred. 25 The bridge is substituted with at least two substituents. Preferably the bridge is substituted with two to four substituents and more preferably with two to three substituents. Most preferably the bridge is : substituted with two substituents. The substituents can v 30 be substituted to any part of the bridge, but are preferably substituted on carbon atoms of the bridging group connected to M1 and M2. A preferred bridging group is thus a bridging group R having from 2 to 6 carbon atoms in the bridge, wherein the carbon atoms of the } bridging group connected to M1 and M2 are both substituted with at least one substituent. The carbon . 5 atoms of the bridging group connected to M1 and M2 are preferably substituted with only one substitutent, but they can be substituted with two substituents.
In addition to the carbon atoms connected to Ml and
MZ, the bridging group can be substituted at other parts, with any kind of substituent, including heteroatoms, alkylgroups, cycloalkyl groups and aryl groups.
In case the substituents are substituted at carbon atoms of the bridge connected to the atoms M1 and MZ, the bidentate ligand has chiral C-atoms and can have a R,R, 5,5 or R,S meso form or mixtures thereof. Both the meso form as well as racemic mixtures can be used.
The substituents on the bridge can be independent or connected. If the substituents are connected, the whole of the substituents and the bridge together can form a bridging group that is an aliphatic ring structure as described herein before. The substituents can further contain carbon atoms and/or hetero atoms.
Suitable substituents include groups containing hetero-atoms such as halides, sulphur, phosphorus, oxygen and nitrogen. Examples of such groups include chloride, bromide, iodide, thiol, and groups of the general formula
H-0-, Xl-0-, -s-x1, -co-xI, -mH,, -Nmxl, -Nx1x2, -co- . Nx1x2, -OH, -PO4, -NOy, -NOH, -CO, -SOp, -SOH, in which * xl and XZ, independently, represent aliphatic groups, preferably having from 1 to 10 carbon atoms, more preferably having from 1 to 4 carbon atoms, like methyl, ethyl, propyl and isopropyl.
Preferably the substituents are hydrocarbyl groups. ) The hydrocarbyl groups itself can be aromatic, aliphatic or cycloaliphatic. The hydrocarbyl groups can contain carbon atoms and hetero atoms. Suitable hydrocarbyl groups can further include groups containing hetero-atoms such as the ones mentioned hereinabove. The hydrocarbyl groups include straight-chain or branched saturated or non-saturated carbon containing groups.
Suitable aromatic hydrocarbyl groups include aryl groups such as phenyl groups or naphtyl groups, and alkyl phenyl groups such as tolyl groups. Of these, substitution with phenyl groups is preferred.
Preferably the hydrocarbyl groups are alkyl groups, preferably having from 1 to 10 carbon atoms, more preferably from 1 to 4 carbon atoms. Linear, branched or cyclic alkyl groups can be used. Suitable alkyl groups include, methyl, ethyl, propyl, iso-propyl, butyl and iso-butyl. More suitably methyl groups are used.
Most preferably the bridge is di-substituted, preferably with two alkyl groups, most preferably with two methyl groups. In an advantageous embodiment the substitution is vicinal.
Examples of bivalent aliphatic bridging groups that can be used include cyclopentane, cyclopentene, cyclohexane, cyclohexene, butane, l-butene, 2-butene, pentane, 2-pentene, diphenylethane, diethylether, . 1,2-diphenylpropane, 2,3-diphenylbutane. * 30 Rl, RZ, R3 and R% can independently represent a ) tertiary alkyl group. By a tertiary alkyl group is understood an alkyl group which is connected to the phosphorus atom by a tertiary carbon atom. The tertiary alkyl group preferably has from 4 to 20 carbon atoms, more preferably from 4 to 8 carbon atoms. Examples of suitable non-cyclic tertiary alkyl groups are tertiary butyl, Zz-(2-methyl)butyl, 2-(2-ethyl)butyl, 2-(2-methyl)pentyl and 2-(2-ethyl)pentyl groups.
Preferably the groups Rl to Rr4 represent the same tertiary alkyl groups, most preferably Rl to RY are tert- butyl groups.
Examples of possible ligands include 2, 3-bis(di- tertiarybutylphosphino)butane, 2,3-bis(di-tertiary- butylphosphino)butene, 2,4-bis(di-tertiarybutylphos- phino)pentane, 2,4-bis(di-tertiarybutylphosphinoc)pentene, 1,2-bis(di-tertiarybutylphosphino)cyclopentane, 1,2-bis(di~-tertiarybutylphosphino)pent-l-ene, 2,3-bis(di- tertiary-butylphosphino) pentane, 2,4-bis(di-tertiary- butylphosphino) hexane, 3,4-bis(di-tertiary-butyl- phosphino) hexane, 2,3~-bis[di-2-(2-methyl)butyl- phosphinolbutane, 2,3-bis[di-2-(2-ethyl)butyl- phosphino]butane. A very suitable bidentate diphosphine is 2,4-bis{(di-tertiarybutylphosphino) pentane.
Rl and RZ together and/or R3 and R% together can also represent an optionally substituted bivalent cyclo- aliphatic group.
A special class of bivalent cycloaliphatic groups include tertiary cyclic structures. For example Rl and RZ and/or R3 and R%4 can represent a bivalent radical that together with the phosphorus atom to which it is attached is an alkyl substituted 2-phosphatricyclo[3.3.1.1{3,7}]- decyl group or a derivative thereof in which one or more . 30 of the carbon atoms are replaced by heteroatoms.
Preferably the ligand comprising the alkyl substituted 2-phospha-~tricyclo[3.3.1.1{3,7}]decyl group is a compound according to Formula III, wherein R2 are alkyl groups of 1-6 carbon atoms, preferably methyl. : — R —
P
: RS P RS R® R®
Oo 0 ge
Oo
RS
RS
Examples of possible ligands include 2,3-P,P’-di(2- phospha-1, 3,5, 7-tetramethyl-6, 9, 10-trioxatricyclo- [3.3.1.1{3.7}decyl)butane and 2,4-P,P’-di (2-phospha- 1,3,5,7-tetramethyl-6,9,10-trioxatricyclo[3.3.1.1{3.7}- decyl)pentane. Such ligands can be prepared as described in more detail in WO-A-9842717.
In an especially preferred embodiment Rl and RZ together and/or R3 and R4 together represent an optionally substituted bivalent cycloaliphatic group.
More preferably both Rl and RZ together and R3 and R4 together represent such an optionally substituted bivalent cycloaliphatic group. This optionally substituted bivalent cycloaliphatic group preferably comprises at least 5 ring atoms and more preferably contains from 6 to 10 ring atoms. It is advantageous that the cycloaliphatic group is a cycloalkylene group, i.e. } forming with the atom Ml or M2 a bicyclic group.
Preferably Ml and M2 are both phosphorus and Rl, R2 and
M1 together and R3, R% and M2 together both represent a pPhosphabicylocalkyl group. In a highly preferred embodiment the cyclic group contains 8 ring atoms and forms a 9-phosphabicyclononyl group together with a } phosphorus atom. The 9-phosphabicyclononyl group can have several isomeric structures. For the purpose of the invention the [3,3,1] and [4,2,1] isomers are preferred.
Rl and RZ together and R3 and R4 together can have both the same or each a different isomeric structure.
Preferably both Rl and R? together and R3 and Rr together have the [3,3,1] structure. Compositions of bidentate diphosphines having a high amount of bidentate diphosphine ligand having the [3,3,1] structure for both phosphabicyclononyl groups can be prepared as described in non-pre-published European patent application
No. 01300866.9.
Substituents of the bivalent cycloaliphatic group formed by RI together with RZ or R3 together with R4, if any, can be alkyl groups having from 1 to 4 carbon atoms.
As a rule, all ring atoms are carbon atoms, but bivalent cyclic groups containing one or more heteroatoms in the ring, such as for example oxygen or nitrogen, atoms are not precluded. Examples of suitable bivalent cyclic groups are 1,4-cyclohexylene, 1,4-cycloheptylene, 1,3-cycloheptylene, 1,2-cyclooctylene, 1,3-cyclooctylene, 1,4-cyclooctylene, 1,5-cyclooctylene, 2-methyl-1,5-cyclo- octylene, 2,6-dimethyl-1,4-cyclooctylene and 2, 6- dimethyl-1, 5-cyclooctylene groups. Preferred bivalent cyclic groups are selected from 1,4-cyclo-octylene, ’ 1,5-cyclo-octylene, and methyl (di)substituted derivatives thereof.
Examples of preferred bidentate ligands include 2,3-PP' bis (9-phosphabicyclo[3, 3, 11nonyl) -butane,
2,3-PP'bis (9-phosphabicyclo (4,2, 1]lnonyl)-butane, 2,3-PP’ bis (9-phosphabicyclo[3, 3, 1l]lnonyl)-but-2-ene, 2,3-PP’ bis (9-phosphabicyclo[4, 2, l]nonyl)-but-2-ene, ’ 2,3-PP’ bis (S-phosphabicyclo (3,3, 1lnonyl) -pentane, 2,4-PP’ bis (9-phosphabicyclo[3, 3, 1lncnyl)-pentane, 2,3-PP’ bis (9-phosphabicyclo[4, 2, 11nonyl)-pentane, 2,4-PP’bis (9-phosphabicyclo[4,2,1]lnonyl)-pentane, 2,3-PP’'bis (9-phosphabicyclo[3, 3,1]lnonyl)-pent-2-ene, 2,3-PP’ bis (9-phosphabicyclo[4,2,l]lnonyl)-pent-2-ene, 1,2-PP’ bis (9-phosphabicyclo[3, 3, 1lnonyl)-cyclopentane, 1,2-PP"bis (9~-phosphabicyclo[4,2,1l]lnonyl)-cyclopentane, 1,2-PP’bis(9-phosphabicyclo[3, 3, 1lnonyl)-cyclohexane, 1,2-PP’' bis (9-phosphabicyclo[4,2, 1lnonyl)-cyclohexane and mixtures thereof.
These ligands can be prepared by reacting P-cyclo- octylene hydride (phosphabicyclononane hydride) and butyllithium to generate a lithium cyclo-octylene phosphide (lithiated phosphabicyclononane). The later phosphide is reacted with an aliphatic group substituted with suitable leaving groups, preferably tosylates or cyclic sulfates, in an appropriate manner. Preferred aliphatic groups are those having a cyclic sulfate structure as a leaving group, such as cyclic substituted or non-substituted alkane diol sulfate esters, also called cyclic alkyl sulfates. For example 2, 4-PP'bis(9- phosphabicyclo[3,3,1]nonyl)-pentane can be prepared by reacting phosphabicyclononane hydride and butyllithium to generate the corresponding lithium phosphide and i subsequently reacting this lithium phosphide, at for example 0 °C or ambient temperature (25 °C) in ‘ tetrahydrofuran, with 2,4 pentanediol di-p-tosylate ester. 2,3-PP’bis(9-phosphabicyclo[3,3,1llnonyl)-butane can for example be prepared by reacting phosphabicyclononane hydride and butyllithium to generate the corresponding lithium phosphide and subsequently reacting this lithium phosphide with 2,3-butanediol cyclic sulfate ester (IUPAC name cyclic Z,3-butyl sulfate), in for example tetrahydrofuran at a temperature varying in the range from 0 °C to reflux temperature.
The P-cyclo-octylene hydride (phoshabicyclononane hydride) may conveniently be prepared as described by
Elsner et al. (Chem. Abstr. 1978, vol. 89, 180154x).
The invention further provides a catalyst system including: (a) a source of group VIII metal cations; (b) a bidentate ligand as described above; and {c) a source of anions.
In the present specification the group VIII metals are defined as the metals rhodium, nickel, palladium and platinum. Of these, palladium and platinum are preferred.
Examples of suitable metal sources are platinum or palladium compounds such as salts of palladium or platinum and nitric acid, sulphuric acid or sulphonic acids, salts of platinum or palladium and carboxylic acids with up to 12 carbon atoms, palladium- or platinum complexes, e.g. with carbon monoxide or acetylacetonate, or palladium or platinum combined with a solid material such as an ion exchanger. Palladium(II) acetate and platinum (II) acetylacetonate are examples of preferred metal sources.
As anion source, any compound generating these anions . may be used. Suitably, acids, or salts thereof, are used as source of anions, for example any of the acids . mentioned above, which may also participate in the salts of the metals of the platinum group.
In the catalyst systems of the invention, preferably acids are used as anion source having a pKa value of less than 6, more preferably less than 5, measured in agueous ' solution at 18 °C.
Typical examples of suitable anions are anions of carboxylic acids, phosphoric acid, sulphuric acid, sulphonic acids and halogenated carboxylic acids such as trifluoroacetic acid.
Carboxylic acids that can be used include carboxylic acids with up to 12 carbon atoms, such as for example, pentanoic acid, pivalic acid, propionic acid and propenoic acid.
Sulphonic acids are in particular preferred, for example methanesulphonic acid, trifluoromethanesulphonic acid, tert-butane-sulphonic acid, p-toluenesulphonic acid and 2,4, 6-trimethylbenzene-sulphonic acid..
Also, complex anions are suitable, such as the anions generated by a combination of a Lewis acid such as BF3,
AlCl3z, SnFp, Sn(CF38013)2, SnCls or GeCly, with a protic acid, such as a sulphonic acid, e.g. CF3SO3H or CH3SO03H or a hydrohalogenic acid such as HF of HCl, or a combination of a Lewis acid with an alcohol. Examples of such complex anions are BF4-, SnCli3-, [SnCl,.CF3S0O3]- and
PFg—.
The invention further provides a process for the carbonylation of optionally substituted ethylenically or acetylenically unsaturated compounds by reaction with carbon monoxide and a coreactant in the presence of a catalyst system as described above.
The ethylenically or acetylenically unsaturated compound, used as starting material, is preferably an ethylenically or acetylenically unsaturated compound having from 2 to 20 carbon atoms per molecule, or a mixture thereof. They may comprise one or more unsaturated bonds per molecule. Preferred are compounds having from Z to 6 carbon atoms, or mixtures thereof. The ethylenically or acetylenically unsaturated compound can further comprise functional groups or heteroatoms, such as nitrogen, sulphur or oxide. Examples include unsaturated carboxylic acids, esters of such acids or alkene nitriles.
In a preferred embodiment the ethylenically or acetylenically unsaturated compound is an olefin or mixture of olefins. In a preferred process of the invention, such olefins can be converted by reaction with carbon monoxide and a coreactant with a high regioselectivity towards the linear product. Suitable ethylenically or acetylenically unsaturated compounds include for example acetylene, ethene, propene, butene, isobutene, pentene, pentene nitriles and methyl 3-pentenoates.
In the process of the invention, the unsaturated starting material and the formed product may act as reaction diluent. Hence, the use of a separate solvent is not necessary. Conveniently, however, the carbonylation reaction may be carried out in the additional presence of a solvent. As such, saturated hydrocarbons, e.g. paraffins and isoalkanes are recommended and furthermore alcohols, the saturated hydrocarbons and alcohols preferably having from 4 to 10 carbon atoms per molecule, such as butanol, ethylhexanol-1l, nonanol-1, or in general terms the alcohols formed as carbonylation product; : ethers such as 2,5,8-trioxanonane (diglyme), diethylether and anisole, and ketones, such as methylbutylketone.
Solvents, comprising or substantially consisting of sulphones are also preferred. Sulphones are in particular preferred, for example dialkylsulphones such as dimethyl- sulphone and diethylsulphone and cyclic sulphones, such ) as sulfolane {(tetrahydrothiophene-2,Z-dioxide), sulfolane, 2-methylsulfolane and 2-methyl-4-ethyl- sulfolane.
The quantity in which the catalyst system is used, is not critical and may vary within wide limits. Usually amounts in the range of 108 to 10-1, preferably in the range of 10” to 1072 mole atom of Group VIII metal per mole of ethylenically unsaturated compound are used. The amounts of the participants in the catalyst system are conveniently selected such that per mole atom of platinum group metal from 0.5 to 10, preferably from 1 to 6 moles of bidentate ligand are used, from 0.5 to 15, preferably from 1 to 8 moles of anion source or a complex anion source.
Furthermore the presence of a small amount of catalyst promoter comprising a source of halide anions, such as for example HI or HCl, can have a significant favourable effect in that the conversion reaction proceeds at high rate, even at moderate temperatures.
For hydroformylation the coreactant can be molecular hydrogen, or more generally a hydride source. The carbon monoxide and hydrogen may be supplied in equimolar or non-equimolar ratios, e.g. in a ratio within the range of 5:1 to 1:5, preferably 3:1 to 1:3. Preferably they are supplied in a ratio within the range of 2:1 to 1:2.
The carbonylation can be suitably carried out at moderate reaction conditions. Hence temperatures in the ’ range of 50 to 200 °C are recommended, preferred temperatures being in the range of 70 to 160 °C. Reaction pressures in the range of 5 to 100 bar are preferred, lower or higher pressures may be selected, but are not considered particularly advantageous. Moreover, higher pressures require special equipment provisions.
The claimed catalyst system can also be useful in conversion reactions other than hydroformylation. In general the coreactant can be represented by NuH, wherein
Nu represents the remnant nucleophilic moiety of the coreactant after removal of a hydrogen atom. The nature of the coreactant largely determines the type of product formed. Preferably the coreactant is a nucleophilic compound having a mobile hydrogen atom, such as an alcohol, an acid, an amine or water. For an alcohol XOH (X being the carbon containing part), the XO moiety is represented by Nu and accordingly the product is an ester.
Similarly, the use of an acid XCOOH (Nu = XCOO) will introduce an anhydride group in the product of the monc- carbonylation reaction; the use of ammonia (Nu = NH») or an amine XNHs (Nu = XNH) or XpNH (Nu = XpN) will introduce an amide group; the use of a thiol XSH (Nu = XS) will introduce a thioester group; and the use of water (Nu = OH) will introduce a carboxy group.
Preferred coreactants are water, alkanol and hydrogen.
Preferred alkanols are alkanols with 1 to 20, more preferably with 1 to 6 carbon atoms per molecule and alkanediols with 2-20, more preferably 2 to 6 carbon atoms per molecule. The alkanols can be aliphatic, cycloaliphatic or aromatic. Suitable alkanols in the process of the invention include methanol, ethanol, ethanediol, n-propanol, 1,3-propanediol, iso-propanol,
butanol, iso-butanol, tert.butanol, pentanol, hexanol, cyclohexanol and phenol.
The invention will be illustrated by the following non-limiting examples.
Example 1
Example 1 was carried out in a 250 ml magnetically stirred autoclave. The autoclave was charged with 10 ml of propene, 40 ml anisole and 10 ml sulfolane, 0.25 mmol of platinum(II) acetylacetonate, 0.3 mmol of meso (R,S) 2,3-bis[cyclo-octylene)phosphino]butane, 0.3 mmol SnCljp and 0.3 mmol HCl. After being flushed, the autoclave was pressurized with carbon monoxide and hydrogen to a partial pressure of 30 bar of each. Subsequently, the reactor was sealed and the contents were heated to 100 °C and maintained at that temperature until the reaction was substantially complete. Complete propene conversion occurred in 0.5 hr, the initial rate of carbonylation was 1000 mol CO/grams atom platinum/hour. The initial rate of carbonylation was defined as the mean rate of carbon monoxide consumption over the first 30% propene conversion. After cooling, a sample was taken from the contents of the reactor and analysed by Gas Liquid
Chromatography. The selectivity towards the linear product n-butyraldehyde was 99.0%.
Comparative example A
Example 1 was repeated, except that instead of 0.3 mmol meso 2,3 bis[(cyclo-octylene)phosphino] butane, 0.3 mmol ligand 1,2 bis[(cyclo-octylene)phosphino] ethane was used as ligand. A similar rate of reaction was observed. After analysis by Gas Liquid Chromatography it was found that the selectivity towards the linear product n-butyraldehyde was 095.5%.
Example 2
Example 2 was carried out in a 250 ml magnetically stirred autoclave. The autoclave was charged with 50 ml of butanol, 0.25 mmol of palladium(II) acetate, 0.33 mmol of meso (R,S) 2,3-PP’'bis (phosphabicyclo[3.3.1lnonyl)- butane, 0.75 ml priopionic acid, and 0.025 mmol HI. After being flushed, the autoclave was pressurized with carbon monoxide to a partial pressure of 15 bar and ethene to a partial pressure of 10 bar. Subsequently, the reactor was sealed and the contents were heated to 115 °C and maintained at that temperature during 1 hour. The initial rate of carbonylation was 1490 mol CO/grams atom palladium/hour. The initial rate of carbonylation was defined as the mean rate of carbon monoxide consumption over the first 30% ethene conversion. After cooling, a sample was taken from the contents of the reactor and analysed by Gas Liquid Chromatography. Conversion was essentially 100%. The selectivity towards butylpropionate was 99%.
Comparative example B
Example 2 was repeated, except that instead of 0.33 mmol of meso (R,S) 2,3-PP’'bis(phosphabicyclo(3.3.1]- nonyl)butane, 0.4 mmol 1,2~PP’bis(9-phosphabicyclononyl)- ethane) was used as ligand. The initial rate of carbonyl- ation was 840 mol CO/grams atom palladium/hour.
Conversion was essentially 100%. A similar selectivity towards butylpropionate was observed.
Example 3 : Example 3 was carried out in a 250 ml magnetically stirred autoclave. The autoclave was charged with 30 mil ' of butanol-1l, 0.25 mmol of platinum(IIl) acetylacetonate, 0.3 mmol of meso (R,S) 2,3-PP’'bis{(phosphabicyclo[3.3.1}- nonyl)butane, 30 ml diglyme, 0.3 mmol phosphoric acid.

Claims (13)

  1. ) 1. Bidentate ligand of formula II, RIRZMI-R-M2R3R4 (II) wherein M1 and M2 are independently P, As or Sb; Rl, RZ, R3 and rR4 independently represent tertiary alkyl groups, or Rl and RZ together and/or R3 and R%4 together represent an optionally substituted bivalent cycloaliphatic group whereby the two free valencies are linked to Ml or MZ, and R represents a bivalent aliphatic bridging group containing from 2 to 6 atoms in the bridge, which is substituted with two or more substituents.
  2. 2. A bidentate ligand as claimed in claim 1, wherein both Ml and M2 are phosphorus atoms.
  3. 3. A bidentate ligand as claimed in claim 1 or 2, wherein the bridging group contains from 2 to 4 carbon atoms in the bridge.
  4. 4. A bidentate ligand as claimed in any one of claims 1-3, wherein substituents are substituted at carbon-atoms of the bridging group connected with the atoms M1 and M2.
  5. 5. A bidentate ligand as claimed in any one of claims 1-4, wherein the substituents are alkyl groups.
  6. 6. A bidentate ligand as claimed in any one of claims 1-5, wherein Rl and R? and/or R3 and R% together represent a bivalent substituted or non-substituted , 25 cycloalkylene group having from 6 to and including 9 ring atoms, whereby the two free valencies are linked to Ml or : M2.
  7. 7. A catalyst system including: (a) a source of group VIII metal cations; (b) a bidentate ligand as claimed in any of the claims 1-6; and : (c) a source of anions. Co
  8. 8. A process for the carbonylation of optionally substituted ethylenically or acetylenically unsaturated compounds by reaction with carbon monoxide and a coreactant in the presence of a catalyst system as claimed in claim 7.
  9. 9. A process as claimed in claim 8, wherein hydrogen is used as coreactant.
  10. 10. A process as claimed in claim 8, wherein a nucleophilic compound having a mobile hydrogen atom is used as coreactant. :
  11. 11. A bidentate ligand as claimed in claim 1, substantially as herein described and exemplified.
  12. 12. A catalyst system as claimed in claim 7, substantially as herein described and exemplified.
  13. 13. A process as claimed in claim 8, substantially as herein described and exemplified. 21 AMENDED SHEET
ZA200209309A 2000-05-17 2002-11-15 Bidentate ligands useful in catalyst system. ZA200209309B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00304171 2000-05-17

Publications (1)

Publication Number Publication Date
ZA200209309B true ZA200209309B (en) 2003-07-29

Family

ID=8172999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200209309A ZA200209309B (en) 2000-05-17 2002-11-15 Bidentate ligands useful in catalyst system.

Country Status (16)

Country Link
US (1) US6639091B2 (en)
EP (1) EP1282629B2 (en)
JP (1) JP5390734B2 (en)
KR (1) KR100744207B1 (en)
CN (1) CN1216889C (en)
AT (1) ATE258936T1 (en)
AU (2) AU2001274046B2 (en)
BR (1) BRPI0110882B1 (en)
CA (1) CA2408862C (en)
DE (1) DE60101963T3 (en)
ES (1) ES2210170T5 (en)
MX (1) MXPA02011237A (en)
MY (1) MY127093A (en)
TW (1) TWI287017B (en)
WO (1) WO2001087899A1 (en)
ZA (1) ZA200209309B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184431B1 (en) * 1999-08-23 2001-02-06 Shell Oil Company Process for separating internal and alpha olefins from saturated compounds
WO2002014248A2 (en) * 2000-08-14 2002-02-21 Sasol Technology (Proprietary) Limited Bicyclic phosphin comprising hydroformylation catalyst and use thereof in production of oxygenated products
AU2002254887A1 (en) * 2001-01-31 2002-08-28 Shell Internationale Research Maatschappij B.V. Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and processes for preparation of this bidentate diphosphine composition
DE10148712A1 (en) * 2001-10-02 2003-04-17 Basf Ag New 2-phosphatricyclodecane diphosphine derivatives useful as components of palladium catalysts for carbonylating conjugated dienes
AU2002363378A1 (en) * 2001-11-09 2003-05-19 Shell Internationale Research Maatschappij B.V. Bidentate ligands for the carbonylation of unsaturated compounds
US6806391B2 (en) 2002-07-31 2004-10-19 Shell Oil Company Process for the carbonylation of ethylenically unsaturated compounds and bidentate diphosphine composition used in this process
US7084089B2 (en) 2002-07-31 2006-08-01 Shell Oil Company Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and a process for preparation of this bidentate diphosphine composition
AU2003299066A1 (en) * 2002-09-26 2004-04-19 Shell Internationale Research Maatschappij B.V. Process for the hydroformylation of an ethylenically unsaturated compound using a bidentate diphosphine composition with a bridging group comprising sp2 hybridized carbon atoms bound to the phosphorous atoms
CA2500107A1 (en) 2002-09-26 2004-04-08 Shell Internationale Research Maatschappij B.V. Process for the production of primary alcohols
GB0403592D0 (en) 2004-02-18 2004-03-24 Lucite Int Uk Ltd A catalyst system
US7265242B2 (en) * 2004-02-26 2007-09-04 Shell Oil Company Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
US7013601B2 (en) * 2004-07-22 2006-03-21 Coastal Planters, Llc Plant container with hanger
GB0516556D0 (en) * 2005-08-12 2005-09-21 Lucite Int Uk Ltd Improved catalyst system
EA025600B1 (en) 2005-11-17 2017-01-30 ЛУСАЙТ ИНТЕРНЕЙШНЛ Ю Кей ЛИМИТЕД Process for carbonylation of ethylenically unsaturated compounds, catalyst system and bidentate ligand
GB0607494D0 (en) * 2006-04-13 2006-05-24 Lucite Int Uk Ltd Metal complexes
GB2437930A (en) * 2006-05-10 2007-11-14 Lucite Int Uk Ltd Mixing apparatus
WO2008065448A1 (en) 2006-12-02 2008-06-05 Lucite International Uk Limited Novel carbonylation ligands and their use in the carbonylation of ethylenically unsaturated compounds
KR100985955B1 (en) * 2008-03-25 2010-10-06 김경수 Skin care apparatus
GB0812297D0 (en) * 2008-07-04 2008-08-13 Lucite Int Uk Ltd Novel carbonylation ligand sand thier use of in the carbonylation of ethylenically unsaturated compounds
US20100069679A1 (en) * 2008-09-12 2010-03-18 Eastman Chemical Company Acetylene tolerant hydroformylation catalysts
EP2213645A1 (en) 2009-01-28 2010-08-04 Hexion Specialty Chemicals Research Belgium S.A. Process for the preparation of an allyl aryl ether by catalytic o-allylation
EP2213643A1 (en) 2009-01-28 2010-08-04 Hexion Specialty Chemicals Research Belgium S.A. Process for the preparation of an allyl aryl ether by catalytic o-allylation
EP2213644A1 (en) 2009-01-28 2010-08-04 Hexion Specialty Chemicals Research Belgium S.A. Process for the preparation of an allyl alkyl ether by catalyic allylation
GB201000078D0 (en) * 2010-01-05 2010-02-17 Lucite Int Uk Ltd Process for the carbonylation of ethylenically unsaturated compounds, novel carbonylation ligands and catalyst systems incorporatng such ligands
US9540440B2 (en) 2013-10-30 2017-01-10 Cytomx Therapeutics, Inc. Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
WO2015089283A1 (en) 2013-12-11 2015-06-18 Cytomx Therapeutics, Inc. Antibodies that bind activatable antibodies and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2880222A (en) * 1957-02-06 1959-03-31 Ernst A H Friedheim Organic dithiol derivatives
US3035052A (en) * 1959-03-02 1962-05-15 Ernst A H Friedheim Arsenic-containing derivatives of dimercapto-succinic acid
GB1127965A (en) * 1965-11-26 1968-09-25 Shell Int Research Ditertiary phosphines and application thereof as catalyst components for alcohol production
JPS58103537A (en) * 1981-12-15 1983-06-20 Adeka Argus Chem Co Ltd Stabilized synthetic resin composition
DE4026406A1 (en) * 1990-08-21 1992-02-27 Basf Ag RHODIUM HYDROFORMYLATION CATALYSTS WITH BIS-PHOSPHITE LIGANDS
EP0495547B1 (en) * 1991-01-15 1996-04-24 Shell Internationale Researchmaatschappij B.V. Carbonylation of olefins
ES2077337T3 (en) * 1991-01-15 1995-11-16 Shell Int Research PROCEDURE FOR THE CARBONILATION OF OLEPHINS.
CA2086285A1 (en) * 1992-12-24 1994-06-25 Colleen Elizabeth Micklethwaite Process for the preparation of vicinally-disubstituted bis(diorganophosphino) compounds
DE69414578T2 (en) * 1993-08-19 1999-05-20 Shell Internationale Research Maatschappij B.V., Den Haag/S'gravenhage HYDROFORMYLATION PROCESS
GB9425911D0 (en) * 1994-12-22 1995-02-22 Ici Plc Process for the carbonylation of olefins and catalyst system for use therein
US5495041A (en) 1995-02-22 1996-02-27 Dsm N.W. Process for the preparation of a pentenoate ester
FR2761071B1 (en) † 1997-03-20 1999-12-03 Synthelabo DERIVATIVES OF QUINOLEIN-2 (1H) -ONE AND DIHYDROQUINOLEIN-2 (1H) - ONE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US6156934A (en) * 1997-03-26 2000-12-05 Shell Oil Company Diphosphines
DE19840253A1 (en) 1998-09-03 2000-03-09 Basf Ag Process for the preparation of cyanvaleric acid or esters

Also Published As

Publication number Publication date
CA2408862A1 (en) 2001-11-22
EP1282629B2 (en) 2007-04-11
ES2210170T5 (en) 2007-11-01
KR100744207B1 (en) 2007-07-30
AU2001274046B2 (en) 2004-05-06
JP2003533534A (en) 2003-11-11
ATE258936T1 (en) 2004-02-15
DE60101963D1 (en) 2004-03-11
BRPI0110882B1 (en) 2015-12-22
JP5390734B2 (en) 2014-01-15
DE60101963T3 (en) 2007-10-18
WO2001087899A1 (en) 2001-11-22
US20020016484A1 (en) 2002-02-07
CN1216889C (en) 2005-08-31
DE60101963T2 (en) 2004-12-23
TWI287017B (en) 2007-09-21
ES2210170T3 (en) 2004-07-01
EP1282629A1 (en) 2003-02-12
MY127093A (en) 2006-11-30
CA2408862C (en) 2010-02-16
KR20020094051A (en) 2002-12-16
EP1282629B1 (en) 2004-02-04
CN1429228A (en) 2003-07-09
BR0110882A (en) 2003-06-10
MXPA02011237A (en) 2003-04-25
US6639091B2 (en) 2003-10-28
AU7404601A (en) 2001-11-26

Similar Documents

Publication Publication Date Title
CA2408862C (en) Bidentate ligands useful in catalyst system
AU2001274046A1 (en) Bidentate ligands useful in catalyst system
US6156934A (en) Diphosphines
JP4474419B2 (en) Method for preparing glycolaldehyde
EP1478463B1 (en) Process for the carbonylation of an ethylenically unsaturated compound and catalyst therefore
EP1000003A1 (en) Hydrogenolysis of glycerol
US20070238892A1 (en) Process for the hydroformylation of an ethylenically unsaturated compound
US5488174A (en) Hydroformylation process
EP1444241B1 (en) Bidendate ligands for the carbonylation of unsaturated compounds
CA2238758C (en) Process for the carbonylation of acetylenically unsaturated compounds
EP0689529B1 (en) Process for the carbonylation of acetylenically unsaturated compounds
US5364970A (en) Process for the hydroformylation of unsaturated carbonyl compounds
EP0891321B1 (en) Process for the carbonylation of acetylenically unsaturated compounds
US5952522A (en) Process for the carbonylation of acetylenically unsaturated compounds
KR100285942B1 (en) Method for preparing alkanedic acid derivatives
WO2004029014A1 (en) Process for the production of primary alcohols